日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Lattice Radiation Therapy Plays a Synergistic Role in the Radical Treatment of Bulky Cervical Cancer: A Case Report and Literature Review

网格放射治疗在巨大宫颈癌根治性治疗中发挥协同作用：病例报告及文献综述

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol33040196
Wang, Feifei; Zhan, Qianru; Dai, Zhitao; Zhang, Huijuan; Peng, Miao; Chen, Zhijian; Jin, Jing; Sheng, Xiugui
宫颈癌
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Myelopreservation with Trilaciclib in recurrent advanced ovarian cancer: a case report

Trilaciclib治疗复发性晚期卵巢癌的骨髓保护：病例报告

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2024.1343239
Tan, Huaming; Han, Xiuchen; Li, Chao; Liu, Wenli; Li, Kanghong; Sheng, Xiugui; Qi, Shuying
肿瘤
肿瘤免疫
卵巢癌
发表日期：2024
文献求助 收藏

Prognostic Value of Body Composition and Systemic Inflammatory Markers in Patients with Locally Advanced Cervical Cancer Following Chemoradiotherapy

化疗放疗后局部晚期宫颈癌患者体成分和全身炎症标志物的预后价值

期刊:Journal of Inflammation Research
影响因子:4.1
doi:10.2147/JIR.S435366
Guo, Hui; Feng, Shuai; Li, Zhiqiang; Yin, Yueju; Lin, Xueying; Yuan, Lingqin; Sheng, Xiugui; Li, Dapeng
肿瘤
炎症
肿瘤免疫
炎症/感染
宫颈癌
发表日期：2023
文献求助 收藏

The HOXC-AS2/miR-876-5p/HKDC1 axis regulates endometrial cancer progression in a high glucose-related tumor microenvironment

HOXC-AS2/miR-876-5p/HKDC1轴在高糖相关的肿瘤微环境中调控子宫内膜癌的进展

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.15384
Guo, Jing; Ye, Feng; Xie, Wenli; Zhang, Xinxin; Zeng, Ru; Sheng, Wang; Mi, Yanjun; Sheng, Xiugui
肿瘤
子宫内膜癌
肿瘤免疫
信号转导
肿瘤微环境
发表日期：2022
文献求助 收藏

Comparing dosimetric and cancer control outcomes after intensity-modulated radiation therapy and tomotherapy for advanced cervical cancer

比较晚期宫颈癌采用调强放射治疗和断层放射治疗后的剂量学和癌症控制结果

期刊:Oncology Letters
影响因子:2.2
doi:10.3892/ol.2022.13359
Li, Dapeng; Wang, Dandan; Feng, Shuai; Chen, Quancai; Sheng, Xiugui; Jia, Jue; Yan, Xiaohui; Zhu, Jian; Yin, Yueju
宫颈癌
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Derlin1 functions as an oncogene in cervical cancer via AKT/mTOR signaling pathway.

Derlin1 通过 AKT/mTOR 信号通路在宫颈癌中发挥癌基因的作用

期刊:Biological Research
影响因子:4.6
doi:10.1186/s40659-019-0215-x
Li Ling, Liu Ming, Zhang Zhihu, Zhang Wei, Liu Naifu, Sheng Xiugui, Wei Ping
信号转导
宫颈癌
mTOR
肿瘤免疫
发表日期：2019
文献求助 收藏

SOX11 hypermethylation as a tumor biomarker in endometrial cancer

SOX11高甲基化作为子宫内膜癌的肿瘤生物标志物

期刊:
影响因子:
doi:10.1016/j.biochi.2019.03.019
Shan, Tianjiao; Uyar, Denise S; Wang, Li-Shu; Mutch, David G; Huang, Tim H-M; Rader, Janet S; Sheng, Xiugui; Huang, Yi-Wen
肿瘤
SOX
子宫内膜癌
肿瘤免疫
表观遗传
发表日期：2019
文献求助 收藏

The role of vitamin D in ovarian cancer: epidemiology, molecular mechanism and prevention

维生素D在卵巢癌中的作用：流行病学、分子机制和预防

期刊:Journal of Ovarian Research
影响因子:4.2
doi:10.1186/s13048-018-0443-7
Guo, Hui; Guo, Jing; Xie, Wenli; Yuan, Lingqin; Sheng, Xiugui
肿瘤
肿瘤免疫
卵巢癌
发表日期：2018
文献求助 收藏

Abdominal radical trachelectomy guided by sentinel lymph node biopsy for stage IB1 cervical cancer with tumors >2 cm

对于肿瘤直径大于2厘米的IB1期宫颈癌，采用前哨淋巴结活检引导下的腹式根治性宫颈切除术

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.13788
Deng, Xiangyun; Zhang, Ying; Li, Dapeng; Zhang, Xiaoling; Guo, Hui; Wang, Fei; Sheng, Xiugui
宫颈癌
肿瘤
肿瘤免疫
发表日期：2017
文献求助 收藏

NT1014, a novel biguanide, inhibits ovarian cancer growth in vitro and in vivo

NT1014是一种新型双胍类药物，可在体外和体内抑制卵巢癌细胞的生长。

期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-016-0325-7
Zhang, Lu; Han, Jianjun; Jackson, Amanda L; Clark, Leslie N; Kilgore, Joshua; Guo, Hui; Livingston, Nick; Batchelor, Kenneth; Yin, Yajie; Gilliam, Timothy P; Gehrig, Paola A; Sheng, Xiugui; Zhou, Chunxiao; Bae-Jump, Victoria L
细胞生物学
肿瘤
肿瘤免疫
卵巢癌
发表日期：2016
文献求助 收藏